Krzysztof Giannopoulos Selected Research

Krzysztof Giannopoulos Research Topics

Disease

24	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 07/2022 - 07/2006
16	Neoplasms (Cancer) 02/2021 - 08/2005
12	Leukemia 04/2021 - 08/2005
9	Multiple Myeloma 07/2022 - 02/2008
9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2019 - 08/2005
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2021 - 12/2006
4	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 08/2005
3	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2019 - 06/2018
2	COVID-19 07/2022 - 01/2022
2	Infections 01/2022 - 01/2011
2	Arthritis (Polyarthritis) 08/2018 - 12/2017
2	Psoriatic Arthritis 06/2018 - 12/2017
2	Autoimmune Diseases (Autoimmune Disease) 10/2016 - 12/2015
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2010 - 02/2008
1	Atrial Fibrillation 01/2020
1	Hemorrhage 01/2020
1	Trisomy (Trisomies) 01/2017
1	Persistent Infection 10/2016
1	Necrosis 01/2014
1	Renal Insufficiency (Renal Failure) 07/2012
1	Carcinogenesis 12/2011
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2011
1	Human Influenza (Influenza) 09/2008
1	Chondrosarcoma 01/2008
1	Pathologic Complete Response 12/2006
1	Residual Neoplasm 12/2006

Drug/Important Bio-Agent (IBA)

9	AntigensIBA 12/2013 - 08/2005
8	Proteins (Proteins, Gene)FDA Link 11/2020 - 07/2006
6	Peptides (Polypeptides)IBA 01/2011 - 08/2005
5	HLA-G Antigens (HLA G)IBA 04/2019 - 07/2012
4	LigandsIBA 01/2022 - 01/2012
4	Thalidomide (Thalomid)FDA Link 03/2015 - 03/2007
3	Messenger RNA (mRNA)IBA 07/2022 - 12/2006
3	Phosphotransferases (Kinase)IBA 07/2021 - 12/2011
3	CytokinesIBA 02/2021 - 12/2017
3	ibrutinibIBA 07/2020 - 10/2017
3	Imatinib Mesylate (Gleevec)FDA Link 07/2017 - 12/2006
3	VaccinesIBA 08/2008 - 08/2005
3	Hyaluronic Acid (Hyaluronan)IBA 02/2008 - 08/2005
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022 - 01/2022
2	Bendamustine Hydrochloride FDA Link 01/2022 - 11/2021
2	Tyrosine (L-Tyrosine)FDA Link 07/2021 - 12/2011
2	Dasatinib (BMS 354825)FDA Link 04/2021 - 01/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020 - 09/2013
2	Neuropilin-1IBA 10/2020 - 09/2013
2	Prostaglandins AIBA 04/2019 - 06/2018
2	Biomarkers (Surrogate Marker)IBA 08/2016 - 07/2006
2	fludarabineIBA 03/2015 - 03/2007
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2015 - 05/2008
2	FibromodulinIBA 09/2008 - 10/2006
2	EpitopesIBA 09/2008 - 08/2005
2	SurvivinIBA 09/2008 - 10/2006
2	EnzymesIBA 04/2006 - 08/2005
1	mRNA VaccinesIBA 07/2022
1	BNT162 VaccineIBA 07/2022
1	2019-nCoV Vaccine mRNA-1273IBA 07/2022
1	AntibodiesIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	venetoclaxIBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	zanubrutinibIBA 01/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 11/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2021
1	EmulsionsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 10/2020
1	daratumumabIBA 09/2019
1	Biotin (Vitamin H)FDA Link 11/2018
1	2,6-bis-trifluoromethylbenzoic acid 2- (1- (ethoxycarbonylmethylcarbamoyl)- 3- methylbutylcarbamoyl)allyl esterIBA 11/2018
1	Therapeutic UsesIBA 11/2018
1	Small Interfering RNA (siRNA)IBA 11/2018
1	CCAAT-Enhancer-Binding ProteinsIBA 11/2018
1	ThioredoxinsIBA 11/2018
1	Protein Disulfide-IsomerasesIBA 11/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2017
1	Bortezomib (Velcade)FDA Link 08/2016
1	Interleukin-17 (Interleukin 17)IBA 12/2015
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2015
1	GlucocorticoidsIBA 01/2014
1	NF-kappa B (NF-kB)IBA 01/2014
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2013
1	Tyrosine Kinase InhibitorsIBA 12/2011
1	Phosphates (Orthophosphate)IBA 12/2011
1	Adenosine Triphosphate (ATP)IBA 12/2011
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2011
1	Lenalidomide (CC 5013)FDA Link 12/2011
1	Protein Subunit VaccinesIBA 07/2010
1	Viral AntigensIBA 09/2008
1	Cancer VaccinesIBA 08/2008
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2007
1	peptide AIBA 12/2006

Therapy/Procedure

11	Immunotherapy 11/2020 - 08/2005
9	Therapeutics 07/2022 - 12/2006
3	Stem Cell Transplantation 11/2007 - 10/2006
2	Salvage Therapy 11/2021 - 01/2008
1	Precision Medicine 08/2021
1	Hematopoietic Stem Cell Transplantation 02/2019
1	Injections 08/2008
1	Drug Therapy (Chemotherapy) 12/2006